EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity

Serena Spartano iD, Maria Vittoria Faggiano, Giovanna Guidi, Pino D'Ambrosio iD, Alessandro Vaisfeld, Agnese Novelli iD, Salvatore Falqui, Antonella Cingolani, Lorenza Lambertenghi iD, Alessandro Visentin iD, Annamaria Azzini iD, Elda Righi und 10 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Serena Spartano und 21 weiteren Autor:innen. Beteiligte Einrichtung: Section of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, HLA Antigens, Haplotypes, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Emergex Vaccines Ltd, Emergex Vaccines Holding Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, responsible for Coronavirus Disease 2019 (COVID-19), exhibits a spectrum of clinical manifestations, ranging from asymptomatic to severe pulmonary dysfunction or death. The variability in COVID-19 severity has largely been attributed to the host’s genetic characteristics, suggesting a polygenic genetic architecture, without significant strong evidence of sex-related genetic differences. In this Italian retrospective case–control study, we investigated the association between COVID-19 severity (severe vs. asymptomatic/oligosymptomatic healed individuals) and HLA gene variants, analyzed by next-generation sequencing (NGS). We identified significant HLA alleles (according to the conventional nomenclature), SNPs and haplotypes in the HLA-B, -C, -F, -DQA1, -DRB1, and -DRB5 genes associated with COVID-19 severity. Interestingly, these variants showed biological sex-related effects. Also, we identified specific haplotypes associated with COVID-19 severity that are shared by different conventional HLA alleles, indicated here as “super-haplotypes”. These haplotypes had a biological sex-specific impact on disease severity and markedly increased the risk of severe COVID-19 compared to the conventional HLA alleles (odds ratio of up to 15). Our data suggest that the revision of the current HLA nomenclature may help to identify variants with a stronger effect on disease susceptibility and that association studies could benefit from the stratification of patients by biological sex. If replicated in other disease models, these findings could help to define the functional diversity in immune response between sexes, also based on the HLA system. Finally, due to the global pandemic’s mortality rate, we hypothesize here that SARS-CoV-2 may have acted as a natural selection trigger, leading to a drift in HLA allelic frequencies in the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HLA AntigensHaplotypesSeverity of Illness IndexAllelesSARS-CoV-2Genetic Predisposition to DiseaseHumansMaleFemaleCase-Control StudiesRetrospective StudiesMiddle AgedAgedSex FactorsPolymorphism, Single NucleotideAdultGene FrequencyItaly

Stichwörter der Autor:innen

COVID-19HLA gene variantsSARS-CoV-2biological sex differencescase–control studygenetic architecturegenetic association studyimmune system modulationnext-generation sequencing

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Section of Genomic Medicine, Department of Life Sciences and Public Health, Catholic University of Sacred Heart, 00168 Rome, Italy.
  • Complex Unit of Medical Genetics, Department of Laboratory and Infectivologic Sciences, Policlinico "A. Gemelli" Foundation, 00168 Rome, Italy.
  • Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of Sacred Heart, 00168 Rome, Italy.
  • Unit of Infectious Diseases, Department of Medical and Surgical Sciences, Policlinico "A. Gemelli" Foundation, 00168 Rome, Italy.
  • Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
  • Infectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, University "Magna Graecia"-"R. Dulbecco", 88100 Catanzaro, Italy.

ORCID-Profile: Serena Spartano, Pino D'Ambrosio, Agnese Novelli, Lorenza Lambertenghi, Alessandro Visentin, Annamaria Azzini, Enrico Maria Trecarichi, Silvano Coletti, Massimo Fantoni, Roberto Cauda, Francesco Danilo Tiziano

Förderung

  • Emergex Vaccines Ltd
  • Emergex Vaccines Holding Ltd.

Zitieren

APA

Spartano, S., Faggiano, M. V., Guidi, G., D'Ambrosio, P., Vaisfeld, A., Novelli, A., Falqui, S., Cingolani, A., Lambertenghi, L., Visentin, A., Azzini, A., Righi, E., Trecarichi, E. M., Mazzitelli, M., Coletti, S., Mous, J., Rademacher, T. W., Torti, C., Tacconelli, E., …, & Tiziano, F. D. (2024). Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313198

Vancouver

Spartano S, Faggiano MV, Guidi G, D'Ambrosio P, Vaisfeld A, Novelli A, et al. Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313198

BibTeX
@article{Spartano2024,
  author = {Spartano, Serena and Faggiano, Maria Vittoria and Guidi, Giovanna and D'Ambrosio, Pino and Vaisfeld, Alessandro and Novelli, Agnese and Falqui, Salvatore and Cingolani, Antonella and Lambertenghi, Lorenza and Visentin, Alessandro and Azzini, Annamaria and Righi, Elda and Trecarichi, Enrico Maria and Mazzitelli, Maria and Coletti, Silvano and Mous, Jan and Rademacher, Thomas W and Torti, Carlo and Tacconelli, Evelina and Fantoni, Massimo and Cauda, Roberto and Tiziano, Francesco Danilo},
  title = {Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313198}
}
Kostenlos starten →